Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.

BACKGROUND: The efficacy of bacille Calmette-Guérin (BCG) may be enhanced by heterologous vaccination strategies that boost the BCG-primed immune response. One leading booster vaccine, MVA85A (where "MVA" denotes "modified vaccinia virus Ankara"), has shown promising safety and...

Full description

Bibliographic Details
Main Authors:	Hawkridge, T, Scriba, T, Gelderbloem, S, Smit, E, Tameris, M, Moyo, S, Lang, T, Veldsman, A, Hatherill, M, Merwe, L, Fletcher, H, Mahomed, H, Hill, A, Hanekom, W, Hussey, G, Mcshane, H
Format:	Journal article
Language:	English
Published:	2008

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.

Similar Items